APEX2 and cancer: McMahon et al. provide the latest insights on the altered expression of APE2 in cancer, on the mechanism of action of APE2 regarding ATR signaling and how this enzyme provides an essential function in some cancers with regard to its role in microhomology mediated end joining (46).